Full website is coming soon

Other

Finding clinical parameters associated with onset of Alzheimer’s disease

Goal
To identify early clinical parameters associated with the onset of Alzheimer’s disease (AD)...
Impact
Early identification of patients at high risk for Alzheimer’s may allow early interventions to prevent or delay the disease progression
Collaborator(s)
Weizmann Institute of Science

As there are no effective treatments to date, identifying individuals with an increased risk to develop Alzheimer’s disease (AD) might allow disease prevention and onset delay strategies. It was established that the systemic immune system has a crucial role in maintaining healthy brain function and repair. Therefore, it is possible that early clinical conditions affecting systemic immunity may contribute to the onset of AD.

 

Our approach includes evaluation of conditions/symptoms that are significantly different between control and Alzheimer’s patients before diagnosis. We aim to stratify symptoms that seem to reflect the progression of the disease and those that are associated with increased risk for AD.

Additional analysis will focus on identifying subgroups of patients that were diagnosed with immune-related conditions and see their association to AD. We will also perform a deep investigation of the relation between drugs and AD.

Want to...





    This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.





      This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.





        This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.